Position in HLN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$19,620
+$8,589 QoQ
Shares Held
2,103
+90.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#443
of 639 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $28,247,477 across 43 Drug Manufacturers - Specialty & Generic names. HLN ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
138,149 | $9,927,387 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
17,634 | $9,554,630 | |
| 3 | VTRS |
Viatris Inc
|
224,551 | $3,565,869 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
7,166 | $794,996 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
4,362 | $735,171 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,073 | $680,073 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
19,095 | $469,927 | |
| 8 | BIOA |
BioAge Labs, Inc.
|
11,977 | $293,556 |
All Filings in HLN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,620 | 2,103 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,031 | 1,102 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $10,110 | 1,000 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,691 | 300 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $3,111 | 300 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,087 | 300 | Shares | Sole | 2025-04-30 | |
| No filing history on record for this holder in this stock. | ||||||